About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

RECRUITINGNCT07335679

Characterization of the Strasbourg Cohort of Patients With Adrenal Cortex Carcinoma

Adrenal corticosteroid carcinoma (ACC) is a rare tumor of the adrenal cortex, with an estimated prevalence of 0.5 to 2 cases per million inhabitants per year. Two peaks in incidence have been describ...

Lead sponsor: University Hospital, Strasbourg, France•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Philippe BALTZINGER, MD

CONTACT

33 3 88 12 75 82 philippe.baltzinger@chru-strasbourg.fr

Sponsors

Lead Sponsor

University Hospital, Strasbourg, France

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Adult subject (≥ 18 years old)
•Subjects followed at Strasbourg University Hospital for adrenal cortical carcinoma diagnosed between January 1, 2000, and May 31, 2025

Exclusion Criteria

•\- Tumor reclassified as non-SCC by histopathology

Related studies

RECRUITINGPhase 2

Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer

NCT06900595 · Locally Advanced Adrenal Cortical Carcinoma, Metastatic Adrenal Cortical Carcinoma, and more

RECRUITINGPhase 2

Cabozantinib in Combination With Pembrolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Adrenal Cortical Cancer

NCT06006013 · Locally Advanced Adrenal Cortex Carcinoma, Adrenal Cortical Carcinoma, and more

RECRUITINGPhase 2

Phase II Study of PD-1 Inhibitor Combined With Apatinib and Mitotane in the Treatment of Advanced Adrenal Cortical Carcinoma

NCT06831175 · Adrenal Cortical Carcinoma, Adrenal Cortical Cancer, and more

Development of Clinical Evidence for Optimal Management of Adrenal Diseases Based on Real-World Data

NCT06229405 · Adrenal Tumor, Primary Aldosteronism, and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 13, 2026Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment60

Start dateJun 2025

Last updatedJan 13, 2026

Condition

Adrenal Cortical Carcinoma

Locations shown

Service d'Endocrinologie, Diabétologie, Nutrition - CHU de Strasbourg - France

Strasbourg

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 13, 2026Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions